Senior management in the HSE sought to remove more than €7 million in funding from the National Cancer Control Programme earlier this year and re-direct it to hospitals. The proposed move led Dr Susan O’Reilly, national director of the National…
Senior management in the HSE sought to remove more than €7 million in funding from the National Cancer Control Programme earlier this year and re-direct it to hospitals. The proposed move led Dr Susan O’Reilly, national director of the National…
Dr Susan O’Reilly told The Irish Times that the target contained in the Dublin Resolution and signed by more than 60 countries at the World Cancer Leaders’ Summit yesterday was “overly optimistic” and did not take into account Ireland’s ageing population. (Times)…
UP to 100 women who develop breast cancer each year will be able to avoid chemotherapy and its potential side-effects thanks to the introduction of a new test in public hospitals. The test — Oncotype DX — is capable of guiding doctors…
More than half of men diagnosed with the disease found the side-effects to be worse than expected and almost 50% were unprepared for the emotional toll of prostate cancer. The research, based on the experience of more than 200 men…
The study found that 98% of men surveyed had side effects as a result of their treatment, including urinary, bowel or sexual issues. More than 54% of those surveyed said the loss of libido after treatment was worse than they…
Dr Susan O’Reilly, director of the National Cancer Control Programme said Ireland could improve its survival rate in many common cancers. They are joined by leading experts in Ireland, including Professor of Clinical Oncology at TCD Donal Hollywood and medical…